Jumia Technologies AG

Jumia Technologies saw a 16.2% stock rally in November after reporting strong Q3 earnings, narrowing losses, and presenting optimistic long-term growth targets through 2030, with a significant price target increase from an analyst.

All Talentz successfully hosted its first hackathon, bringing together African tech talents to develop innovative solutions in healthcare, education, and employment. Team Imago won with an AI-powered maternal healthcare ultrasound device, receiving ₦10 million and a trip to TechCrunch Disrupt 2025.

Three stocks - BioXcel Therapeutics, Telos, and Jumia - have shown significant momentum gains, with substantial price increases and strong performance in Benzinga's momentum rankings over the past week.

Jumia Technologies stock plunged 53.82% after reporting disappointing Q2 results, including a revenue decline and continued losses. The company plans to raise capital through a share offering, potentially diluting existing shareholder value.

Jumia Technologies (JMIA) closed the most recent trading day at $7.28, moving +1.39% from the previous trading session.